Current Trends in IBD—Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System

Abstract Despite recent developments in therapy for inflammatory bowel diseases (IBDs), there have been limited advances in diagnostic tools available to aid in disease management. A growing body of evidence suggests that there are important host-microbe interactions at the mucosal interface that mo...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Inflammatory bowel diseases 2021-11, Vol.27 (Supplement_2), p.S17-S24
Hauptverfasser:	Yau, Yunki Y, Wasinger, Valerie C, Hirten, Robert P, Chuang, Emil, Huntsman, Merodean, Stylli, Jack, Shimizu, Jeff, Yajnik, Vijay, Smith, Jeffrey, Lee, Shaoying N, Singh, Sharat, Wahl, Christopher, Leong, Rupert W, Sands, Bruce E
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Colon Colonoscopy Dysbiosis Humans Inflammatory Bowel Diseases - diagnosis Intestinal Mucosa Supplement
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!